Join
Live feed
·
INSIDERFilingvia Quantisnow
Athira Pharma Inc. logo

Litton Mark James was granted 20,000 shares and sold $14,026 worth of shares (4,820 units at $2.91), increasing direct ownership by 12% to 144,397 units (SEC Form 4) (Amendment)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ATHA (Athira Pharma Inc.) and more on Quantisnow.